Cellebrite DI (CLBT) Other Non-Current Liabilities (2020 - 2025)
Cellebrite DI has reported Other Non-Current Liabilities over the past 6 years, most recently at $16.7 million for Q4 2025.
- Quarterly results put Other Non-Current Liabilities at $16.7 million for Q4 2025, up 139.82% from a year ago — trailing twelve months through Dec 2025 was $16.7 million (up 139.82% YoY), and the annual figure for FY2025 was $16.7 million, up 139.82%.
- Other Non-Current Liabilities for Q4 2025 was $16.7 million at Cellebrite DI, up from $7.0 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for CLBT hit a ceiling of $54.1 million in Q4 2023 and a floor of $5.4 million in Q4 2022.
- Median Other Non-Current Liabilities over the past 5 years was $9.5 million (2021), compared with a mean of $18.5 million.
- Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 903.28% in 2023 and later plummeted 87.15% in 2024.
- Cellebrite DI's Other Non-Current Liabilities stood at $9.5 million in 2021, then tumbled by 43.44% to $5.4 million in 2022, then skyrocketed by 903.28% to $54.1 million in 2023, then plummeted by 87.15% to $7.0 million in 2024, then soared by 139.82% to $16.7 million in 2025.
- The last three reported values for Other Non-Current Liabilities were $16.7 million (Q4 2025), $7.0 million (Q4 2024), and $54.1 million (Q4 2023) per Business Quant data.